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In six patients with urticaria pigmentosa, population 
density and ultrastructure of the cutaneous mast cells 
and histamine levels of the lesional skin were studied 
before, immediately after, a nd again 5-8 months after 
photochemotherapy (PUVA). Immediately after PUVA, 
the total mast cell number was not reduced, but on 
separate analysis of the intradermal distribution, sig-
nificantly fewer mast cells were found in the papillary 
dermis and correspondingly more mast cells in the ad-
jacent upper dermis. On electron microscopic examina-
tion, 4% of the mast cell granules were immature before 
and 27% after PUV A therapy, based on the lower elec-
tron density of the granular matrix. This was associated 
with a markedly lower histamine content of the lesional 
skin. Five to eight months after recovery from PUV A, 
the morphologic changes and the histamine levels had 
a ll returned to the pre-PUV A status. These findings 
were paralleled by a reversal of all clinical beneficial 
effects that had been observed with PUV A. 
Urticaria pigmentosa (UP) is characterized morphologically 
by dermal accumulation of mast cells and clinically by hyper-
p igmentation, itching, and whealing of t he skin . Recent reports 
[1-5 ] have shown that some of t he symptoms can be treated 
successfully with 8-methoxypsoralen in combination with UV A 
irradiation (PUV A). Although the underlying mechanism of 
this therapy is not fully understood, t here is some biochemical 
eviden ce that PUV A t reatment reduces histamine release and 
turnover of t he cutaneous mast cells [1-3]. 
In t he present investigation, we have tried to correlate clin-
ical observations and metabolic changes following PUV A ther-
apy with numerical and/or structural alterations of the cuta-
neous mast cells. Skin biopsies from 6 UP patients have been 
studied before, immediately after, and again several months 
after recovery from PUV A, using histomorphometric as well as 
qua litative and quantitative ul trastructural methods. In paral-
lel, t h e histamine levels in the lesional skin have been deter-
mined in 5 of t he patients. The fin dings of t his investigation 
give new insights in to t he response of cutaneous mast cells to 
PUV A and into t he mechanism of action of t his physicochem-
ical moda li ty in UP treatment. 
MATERIALS AND METHODS 
Patients and Therapy 
The investigation was performed on 6 patients, 3 women and 3 men, 
with a medium age of 54 years (range: 51 - 56 years). All patients had 
suffered from t he adult form of UP for many years. Diagnosis was 
made by typical cli nical appearance and skin histology. The patients 
received 0.5 mg 8- methoxypsoralen per kg body weight 2 h before UVA 
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irradiation. PUVA was given 3-4 t imes a week over a mean period of 
7 weeks, and the mean total dose amounted to 139 joules per cm2 • At 
the end of the t reatment, a ll patients noted a marked reduction of 
itching and whealing. Physical examination revealed fading of the 
hyperpigmented macules which was at least in part due to the PUVA 
tan in the surrounding skin. Five to eight months after recovery from 
PUVA, most of the beneficial effect had disappeared in all patients. 
Further deta ils are described elsewhere.* 
Light and Electron Microscopy 
At the beginning, at t he end, and again 5- 8 months afte r discontin-
uation of PUV A therapy, skin biopsies of the hyperpigmented patches 
were taken from t he trunk by punch biopsy, using deep local anesthesia 
around t he biopsy sites. The excised tissue was fixed in Karnovsky's 
solution [6] (0.1 M cacodylate buffer, pH 7.4) and postfixed in 1.33% 
osm ic acid (0.05 M phosphate buffer, pH 7.4). After dehydration in a 
graded ethanol series, t he tissue was embedded in Epon 812. For light 
microscopy, semithin sections were stained wit h methylene blue and 
basic fuchs in . Electron microscopy was carried out on sections stained 
with uranyl acetate and lead cit rate. 
Morphometric Studies 
Quantitative morphologic analyses were performed on biopsy sam-
ples obtained at the beginning and at the end of PUV A therapy, and 
comprised a histomorphometric evaluation of mast cell numbers and 
an ultrastructural morphometric evaluation of mast cell granules. 
Mast cell coun ts were carried out on vertical sections of the skin at 
a magnification of 1175x by superimposing a square test area of 28,500 
11m2 onto the viewed section (Wild Heerbrugg, Switzerland). From each 
biopsy, 6 subepidermal test areas were evaluated directly beneath the 
dermal-epidermal junction and a further 6 test areas were evaluated in 
the lower part of the upper dermis, 0.5 mm beneath the junctional 
zone. Mean values were calculated from the subepidermal, upper der-
mal, and overall number of mast cells per patient. The data are 
expressed as number of mast cells per mm2 dermal tissue. 
By ultrastructural morphometric analyses , the number and cross-
sectional area of granules for each mast cell were evaluated on a total 
of 20 mast cell micrographs per biopsy. Only those cells showing an 
intersectioned nucleus were recorded on a 35-mm film at a primary 
magn ification of 2000X. The fi lms were projected on a tab le projector 
uni t (enlargement 11 -fold) , and the granule number and area were 
estimated in relation to the cytoplasmic area, using a manual optic 
picture analysis system (M.O.P. KM II, Kontron, Germany). T he mean 
values per patient were calculated from the data of the 20 micrographs. 
The final averages of the morphometric parameters before and after 
PUVA therapy were calculated from the mean values of the 6 patients. 
Statistical analys is included mean va lue, standard deviation, standard 
error, and Student's t-test. 
Histamine Determination 
For analysis of tissue histamine contents, 2-mm biopsies of UP 
lesions were taken from 5 patients at the time of the biopsies for 
morphologic studies. The tissue was weighed, minced, and boiled for 
10 min in 300 pl of Dulbecco's modified Eagle's medium (Seromed, 
Munich, F.R.G.). Aliquots of the t issue supernatants were assayed for 
histamine levels by the spectrofluorometric method after Shore et al 
[7] . The results of the assays were expressed as ng histamine per mg 
fres h tissue and were analyzed for significance with t he Student t-test. 
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T ABLE l. N umber of mast cells (celLs/mm2 dermal tissue) in biopsies of UP lesions 
Before PUY A After PUVA 
Patient Total Number in Number in Total 
Number in Number in 
nu mber the subepi· the upper number 
the subepi- the upper 
dermal space dermis dermal space dermis 
MJ 238 212 264 113 37 189 
BG 363 323 403 293 147 441 
sw 478 411 545 532 275 789 
DH 207 198 216 239 112 366 
SG 132 151 113 77 65 89 
SA 289 187 391 265 96 434 
Mean + SEM 285 + 37.5 247 + 40.5 322 ± 63. 1 253 ± 63.8 122 ± 34.3 385 + 99.2 
RESULT S 
Light M icroscopy and Histomorphometry 
On histologic examination , an increased number of mast cells 
was fo und in t he upper dermis of t he lesional skin before and 
after PUV A t reatment. Compared to unt reated UP, no marked 
reduction of cutaneous mast cells was noted immediately after 
or several months after discont inuation of t herapy. Before and 
again after cessation of PUV A, t he mast cells were distributed 
diffusely in t he upper third of t he dermis, including t he subep-
idermal area. In contrast, t he number of mast cells in t he 
papillary dermis was reduced immediately after PUV A, and at 
the same t ime, an increased number of mast cells was seen in 
t he adjacent upper dermal layers. 
T he resu lts of the mast cell counts a re shown in Table I. T he 
ove ra ll number of mast ce lls in t he lesions was 285 cells/mm2 
(range 132- 4 78 cells/mm2 ) before t he beginning of t reatment, 
and 253 cells/mm 2 (range 77- 532 cells/mm 2) at the end of 
PUV A. T he slight decrease of t he mean value after P UV A was 
not statistically signi fica nt . In unt reated UP, t here was a mod-
erate difference in t he distribut ion of mast cell s in t he test 
areas immediately below t he epidermis and the lower part of 
t he upper dermis (mean: 24 7 cells/mm2 vs 322 cells/mm2). Afte r 
PUV A therapy, the subepidermal space contained only 122 
cells/mm2, while 385 cells/mm2 were found in t he dermal test 
areas. T he numerical decrease of subepidermal mast cells as 
well as t he resul t ing diffe rence in mast cell number between 
subep ide rmal and dermal test areas were statistically signi fi-
cant (p < 0.025). 
Electron Microscopy 
Most of t he ul trastructural features of t he mast cells after 
PUV A did not differ markedly from those observed in unt reated 
UP. T he cell s (F ig la) exhibited a rhomboidal or, more often , 
round shape and the outer cell surface was studded wi th villous 
processes. T he nuclei were cent ra lly located, round or oval in 
shape, and sometimes slightly indented. There were no altera-
t ions of mitochondria, endoplasmic membranes, and Golgi ap-
paratus. Completely degranulated cells with large membrane-
bound cavi t ies and extruded extracellula r granules were seen 
~t t imes in unt reated UP, while t his was observed fa r less 
fr equently after PUV A. 
Mast cell granules showed a greater variabili ty in structure 
and number at t he end of PUV A t herapy (Fig l a ). Scattered 
throughout the cytoplasm, t here were typical osmiophilic gran-
ules and granules wit h a less electron-dense granular matrix. 
T he latter granules (Fig lb ) were of regular size and shape and 
did not exhibit perigranular spaces or remnants of more elec-
tron-dense material, but t hey sometimes contained lamella r 
inclusions. On morphometric analysis, t hese immature granules 
amounted to 27% of the total granule number compared to 4% 
before PUVA t herapy (p < 0.005). The granule number per 
mast cell and t he granule area pe r cytoplasm were not changed 
m most cells. A significant reduction of granule number and 
granule area was, however, found in 12% of the mast cells. 
FIG 1. Ult rastructural features of cutaneous mast ce lls immediately 
after cessation of P UV A t reatment . a, Survey of mast cells showing 
different electron density of the granules (X 4,700). b, Higher magni-
ficat ion of t he mast cell granules. T he immature granules exhibit a less 
electron-dense, fin e or coarse granular matrix (X 12,800) . c, Mast cell 
containing a markedly reduced number of granules. Note the irregularly 
out lined nucleus ( X 4,500) . 
These cell s (Fig l c) displayed only few mature and immature 
granules in the peripheral cytoplasm. Remarkably, all t hese 
changes in granular structure and number were no longer 
evident several mont hs after discont inuation of PUV A t reat-
ment. 
Histamine L evels (Table li) 
The histamine conten t of t he affected skin decreased from a 
mean of 205 ng/mg fresh t issue to 76 ng/mg fresh tissue ( p < 
0.025) immediately after P UVA. Five to eight months after 
cessation of therapy, the histamine amount had increased again 
to a mean of 160 ng/mg fresh t issue, but this increase was not 
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TABLE II. Histamine levels (ng/mg fresh tissue) in biopsies of UP 
lesions 
Patient Before PUVA After PUVA 5 to 8 Months after PUVA 
MJ 215.1 21.9 346.9 
BG 327.3 144.7 178.8 
sw 300.7 72.2 
DH 98.6 99.0 62.9 
SG 81.6 43.4 52.6 
Mean± SEM 204 .6 ± 50.4 76.2 ± 21.5 160.3 ± 68.5 
statistically s ign ificant. As al ready described in healt hy volun-
teers as well as in UP patients [5,8], t here was only a pa rt ia l 
correlation between mast cell counts and histamine levels. 
DISCUSSION 
The beneficial effect of PUV A in t he treatment of UP is 
expr essed prima rily in an improvement of itching and whealing, 
while fading of t he hyperpigmented macules is less pronounced 
[ 1-5]. This may be due in pa rt to the decrease of mast cell 
histamine or to the decrease of histamine release during PUV A 
therapy as observed in this report and in previous reports [1 -
3]. The morphologic findings of the present investigation dem-
onstrate furthermore t hat PUV A induces changes in t he dermal 
distribution and ul trastructure of t he mast cells. 
In accordance with the report of Vella Briffa et a l [5], we did 
not find a marked reduction in t he overall number of cutaneous 
mast ce lls in lesional skin at t he end of P UVA t herapy. The 
intradermal distribution of t he mast cells was, however, 
changed: fewer cell s were obse rved in t he immediate subepider-
mal sp ace, and correspondingly more cell s were found in the 
lower part of t he upper derm is, compared to untreated UP. 
There are several explanat ions fo r t he decrease in t he number 
of t h e uppermost dermal mast cells. PUV A treatment may 
induce an autolysis of these ce ll s, as has been reported for 
psoriat ic kerati nocytes [9] and for epidermal Langerhans cells 
[10-13 ]. Furthermore, t he characteristic inhibi t ion of cell pro-
liferat i on by P UVA [14,15] may play a role in t he change of 
int radermal mast cell distribution. As an a lternative, although 
not very likely, explanation, the uppermost mast cells could 
also have migrated into deeper layers during PUV A therapy. 
The depletion of epidermal Langerhans cells following photo-
chemotherapy is, for example, thought to be caused by a degen-
eration of the cells in the epidermis and a concomitant migra-
tion of the intact cells into deeper dermal layers [10- 13]. Which 
one of these mechanisms, alone or in combinat ion, is respon-
sible for the decrease of the uppermost mast cells after PUV A 
therapy, remains undecided on the basis of the present mor-
phologic studies. 
Decreased histam ine contents as well as changes in int rader-
mal mast cell distribution may expla in the relief of itching and 
whealing observed with PUVA treatment. If one assumes that 
both symptoms are due to histamine release from mast cells 
and t h at t his release is t riggered in turn by mechanical trauma 
to t he skin, it is easy to conceive that mast cells in deeper 
dermal locations are less affected by local pressure on the skin. 
An a lternative explanation may relate to the !'act t hat the 
cutaneous nerve endings t hat are most responsive to histamine-
induced itching are located within the uppermost dermis 
(16,17]. 
On ultrastructural examination, there were slight alterations 
in structure and number of mast cell granules at t he end of 
PUVA t herapy. On morphometric analysis, 27% of t he granules 
exhibited a less electron-dense, granular matrix which is typi-
cally observed in immat ure mast cells [18-22]. In addi t ion , 
about 12% of the cells showed a marked reduction in the 
number of t heir granules. These alterations cannot be attrib-
uted to an increased degranulation since the ul t rastructural 
cha racteristics of type 1 or type 2 degranulation [23] were even 
less frequent in mast cells of PUVA-treated compared to un -
treated UP. The changes of t he granules may therefore be 
considered to represent an increased leakage of granule media-
tors as well as a decreased resynthesis due to the PUV A effect. 
Since t he histamine content of t he skin is essent ia lly a ll of 
mast cell origin [24] and since maturity and number of granules 
correlate to histamine content of t he cells [25], t he ultrast ruc-
tural features observed here fit with t he decreased histamine 
levels measured in lesional skin after PUV A t herapy. 
The present morphologic findings may a lso explain t he re-
currence of the skin lesions after cessation of PUV A treatment. 
Even after long maintenance t reatments, t here was no fu nda-
mental change in mast cell number and structure, a nd the 
observed change in cell maturi ty and int radermal distribution 
were no longer present seve ral mont hs after disconti nuation of 
t herapy. In para llel, t he histamine content of the lesional skin 
had increased again . Thus, the alterations observed with PUV A 
most likely represent a t ransient reaction pattern of t he cuta-
neous mast cells, which is reversible on recovery fro m t he 
therapy. 
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